RankingsPricing
  1. US-listed companies
  2. AGIOS PHARMACEUTICALS, INC.
  3. Financials
  4. Total non-current assets

AGIOS PHARMACEUTICALS, INC.AGIO

Market cap
$1.7B
P/E ratio
SummaryFinancials
Period EndTotal non-current assets (Million USD)YoY (%)
Dec 31, 2024698+575.42%
Dec 31, 2023103-74.56%
Dec 31, 2022406+8.69%
Dec 31, 2021374+72.70%
Dec 31, 2020216-22.49%
Dec 31, 2019279+14.04%
Dec 31, 2018245+44.66%
Dec 31, 2017169+185.69%
Dec 31, 201659-28.44%
Dec 31, 201583-37.49%
Dec 31, 2014132+320.75%
Dec 31, 201331

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)